Growth hormone therapy and respiratory disorders: Long-term follow-up in PWS children

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 9, 2013, Pages

  Berini, Jenny ^a   Spica Russotto, Valeria ^a   Castelnuovo, Paolo ^b   Di Candia, Stefania ^c   Gargantini, Luigi ^d   Grugni, Graziano ^e   Iughetti, Lorenzo ^g   Nespoli, Luigi ^a   Nosetti, Luana ^a   Padoan, Giovanni ^b   Pilotta, Alba ^f   Trifiro, Giuliana ^h   Chiumello, Giuseppe ^c   Salvatoni, Alessandro ^a  

^a Ospedale F del Ponte   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d TREVIGLIO HOSPITAL   (Italy)

^e ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g Laryngology Spedali Civili di Brescia   (Italy)

^h FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ADENOTONSILLAR HYPERTROPHY; ARTICLE; CENTRAL APNEA INDEX; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FIBEROSCOPE; FLEXIBLE FIBEROPTIC ENDOSCOPE; FOLLOW UP; HORMONAL THERAPY; HUMAN; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINIMAL BLOOD OXYGEN SATURATION; OBSERVATIONAL STUDY; OBSTRUCTIVE APNEA HYPOPNEA INDEX; ORGAN SIZE; POLYSOMNOGRAPHY; PRADER WILLI SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY DISTURBANCE INDEX; RESPIRATORY TRACT PARAMETERS; SCHOOL CHILD; SLEEP DISORDERED BREATHING; TONSIL SIZE;

ADENOIDS; CHILD; CHILD, PRESCHOOL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYPERTROPHY; INFANT; MALE; PALATINE TONSIL; POLYSOMNOGRAPHY; PRADER-WILLI SYNDROME; SLEEP APNEA, OBSTRUCTIVE;

EID: 84883683326     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1831     Document Type: Article

References (40)

1. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi Syndrome. Genet Med. 2012;14:10-26.
2. Holsen LM, Savage CR, Martin LE, et al. Importance of reward and prefrontal circuitry in hunger and satiety: Prader-Willi syndrome vs simple obesity. Int J Obes (Lond). 2012;36:638-647.
3. McAllister CJ, Whittington JE, Holland AJ. Development of the eating behavior in Prader-Willi Syndrome: advances in our understanding. Int J Obes (Lond). 2011;35:188-197.
4. Nixon GM, Brouillette RT. Sleep and breathing in Prader-Willi syndrome. Pediatr Pulmonol. 2002;34:209-217.
5. Manni R, Politini L, Nobili L, et al. Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors. Clin Neurophysiol. 2001;112:800-805.
6. Clift S, Dahlitz M, Parkes JD. Sleep apnoea in the Prader-Willi syndrome. J Sleep Res. 1994;3:121-126.
7. Goldberg S, Shatz A, Picard E, et al. Endoscopic findings in children with obstructive sleep apnea: effects of age and hypotonia. Pediatr Pulmonol. 2005;40:205-210.
8. de Lind van Wijngaarden RF, Joosten KF, van den Berg S, et al. The relationship between central adrenal insufficiency and sleep-related breathing disorders in children with Prader-Willi syndrome. J Clin Endocrinol Metab. 2009;94:2387-2393.
9. Carrel AL, Myers SE, Whitman BY, Allen DB. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab. 2002;87:1581-1585.
10. Whitman BY, Myers S, Carrel A, Allen D. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study. Pediatrics. 2002; 109:E35.
11. Lindgren AC, Hellstrom LG, Ritzén EM, Milerad J. Growth hormone treatment increases CO2 response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. Eur J Pediatr. 1999;158:936-940.
12. Eiholzer U, Nordmann Y, L'Allemand D. Fatal outcome of sleep apnoea in PWS during the initial phase of growth hormone treatment. A case report. Horm Res. 2002;58:24-26.
13. Nordmann Y, Eiholzer U, l'Allemand D, Mirjanic S, Markwalder C. Sudden death of an infant with Prader-Willi Sindrome-not a unique case? Biol Neonate. 2002;82:139-141.
14. Van Vliet G, Deal CL, Crock PA, Robitaille Y, Oligny LL. Sudden death in growth hormone-treated children with Prader-Willi syndrome. J Pediatr. 2004;144:129-131.
15. Craig ME, Cowell CT, Larsson P, et al. PriceDAKIGS International Board 2006 Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). Clin Endocrinol (Oxf). 65:178-185.
16. Eiholzer U. Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS. Horm Res. 2005;63:33-39.
17. Grugni G, Livieri C, Corrias A, Sartorio A, Crino A; Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology. Death during GH therapy in children with Prader- Willi syndrome: description of two new cases. J Endocrinol Invest. 2005;28:554-557.
18. Nagai T, Obata K, Tonoki H, et al. Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment. Am J Med Genet A. 2005;136: 45-48.
19. Riedl S, Blümel P, Zwiauer K, Frisch H. Death in two female Prader- Willi syndrome patients during the early phase of growth hormone treatment. Acta Paediatr. 2005;94:974-977.
20. Sacco M, Di Giorgio G. Sudden death in Prader-Willi syndrome during growth hormone therapy. Horm Res. 2005;63:29-32.
21. Tauber M, Diene G, Molinas C, Hébert M. Review of 64 cases of death in children with Prader-Willi syndrome.AmJ Med Genet Part A. 2008;146:881-887.
22. Herlitz H, Jonsson O, Bengtsson BA. Effect of recombinant human growth hormone on cellular sodium metabolism. Clin Sci. 1994;86: 233-237.
23. Bozzola M, De Benedetti F, De Amici M, et al. Stimulating effect of growth hormone on cytokine release in children. Eur J Endocrinol. 2003;149:397-401.
24. Nixon GM, Rodda CP, Davey MJ. Longitudinal association between growth hormone therapy and obstructive sleep apnea in a child with Prader-Willi syndrome. J Clin Endocrinol Metab. 2011; 96:29-33.
25. Al-Saleh S, Al-Naimi A, Hamilton J, Zweerink A, Iaboni A, Narang I. Longitudinal evaluation of sleep-disordered breathing in children with Prader-Willi Syndrome during 2 years of growth hormone therapy. J Pediatr. 2013;162:263-268.e1.
26. Deal CL, Tony M, Hoybye C, Allen DB, Tauber M, Christiansen JS; 2011 GH in PWS Clinical Care Guidelines Workshop Participants. Growth Hormone Research Society Workshop Summary: Consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab. 2013;98:E1072-E1087.
27. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr Suppl. 2006;450:76-85.
28. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85:660-667.
29. Cha K, Chertow GM, Gonzalez J, Lazarus JM, Wilmore DW. Multifrequency bioelectrical impedance estimates the distribution of body water. J Appl Physiol. 1995;79:1316-1319.
30. Iber C, Ancoli-Israel S, Chesson AL, Quan SF; Americam Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Westchester, IL: American Academy of Sleep Medicine; 2007.
31. Muzumdar H, Arens R. Diagnostic issues in pediatric obstructive sleep apnea. Proc Am Thorac Soc. 2008;5:263-273.
32. Brodsky L. Modern assessment of tonsils and adenoids. Pediatr Clin North Am. 1989;36:1551-1569.
33. Wang DY, Bernheim N, Kaufman L, Clement P. Assessment of adenoid size in children by fibreoptic examination. Clin Otolaryngol Allied Sci. 1997;22:172-177.
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
35. Salvatoni A, Berini J, Chiumello G, et al. POI: a score to modulate GH treatment in children with Prader-Willi syndrome. Horm Res Paediatr. 2012;78:201-202.
36. Papaioannou G, Kambas I, Tsaoussoglou M, Panaghiotopoulou- Gartagani P, Chrousos G, KaditisAG.Age-dependent changes in the size of adenotonsillar tissue in childhood: implications for sleepdisordered breathing. J Pediatr. 2013;162:269-274.e4.
37. Haqq AM, Stadler DD, Jackson RH, Rosenfeld RG, Purnell JQ, LaFranchi SH. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab. 2003;88:2206-2212.
38. Carrel AL, Myers SE,WhitmanBY, Eickhoff J, AllenDB.Long-term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi syndrome. J Clin Endocrinol Metab. 2010;95:1131-1136.
39. Salvatoni A, Veronelli E, Nosetti L, et al. Short-term effects of growth hormone treatment on the upper airways of non severely obese children with Prader-Willi syndrome. J Endocrinol Invest. 2009;32:601-605.
40. Meyer SL, Splaingard M, Repaske DR, Zipf W, Atkins J, Jatana K. Outcomes of adenotonsillectomy in patients with Prader-Willi syndrome. Arch Otolaryngol Head Neck Surg. 2012;138:1047-1051.